Metformin use and reduced dementia risk in older adults with type 2 diabetes and delirium | Synapse
March 3, 2026
Metformin use and reduced dementia risk in older adults with type 2 diabetes and delirium
Key Points
Dementia risk is significantly lower among older adults taking metformin compared to those not using it, indicating a potential neuroprotective effect.
Data from a cohort of older adults with type 2 diabetes and delirium show that metformin users have a marked reduction in dementia incidence over time.
Observational analysis identifies cognitive function improvements linked with metformin use through various neurological pathways and biomarkers.
This finding supports the need for further research into metformin's cognitive benefits in diverse populations with type 2 diabetes and related conditions.